3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
3
Breast Neoplasms
2
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Alopecia
1
Interventions
Cyclophosphamide
160
Rituximab
82
Peripheral Blood Stem Cell Transplantation
78
fludarabine phosphate
75
Etoposide
69
Filgrastim
67
Methotrexate
59
Cytarabine
58
Vincristine
50
Mycophenolic Acid
50
Whole-Body Irradiation
48
Radiotherapy
43
Cyclosporine
43
Busulfan
42
Tacrolimus
40
Melphalan
39
Dexamethasone
37
Prednisone
36
Doxorubicin
36
Antilymphocyte Serum
36
fludarabine
31
blinatumomab
27
Methylprednisolone
24
Granulocyte Colony-Stimulating Factor
22
Carmustine
22
Cord Blood Stem Cell Transplantation
21
Calcium Dobesilate
18
CT-P10
18
Inotuzumab Ozogamicin
16
sargramostim
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Burkitt Lymphoma
×
Immunoconjugates
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled